James E. Audia

James E. Audia

Director/Board Member at
Ribon Therapeutics, Inc.
70 year
Health Technology
Consumer Services
Commercial Services

Profile

James E.
Audia
is currently the Director at Ribon Therapeutics, Inc. and a Member at Alzheimer's Association.
Previously, he served as the Independent Director at Constellation Pharmaceuticals, Inc. from 2011 to 2021.
He was also the Executive Director at Chicago Biomedical Consortium from 2017 to 2019.
Additionally, he held the position of Head-Chemistry at Karuna Therapeutics, Inc. from 2019 to 2024.
Dr. Audia obtained his doctorate degree from Yale University and the University of South Carolina.

James E. Audia active positions

CompaniesPositionStart
Director/Board Member 2018-03-31
Corporate Officer/Principal 2019-12-31

Former positions of James E. Audia

CompaniesPositionEnd
KARA THER Corporate Officer/Principal 2024-03-17
CONSTELLATION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2017-06-30
Chicago Biomedical Consortium
Director/Board Member 2019-09-30
See the detail of James E. Audia's experience

Training of James E. Audia

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

55

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Chicago Biomedical Consortium

  1. Stock Market
  2. Insiders
  3. James E. Audia